Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

APOPW - Cellect Biotechnology Ltd. - Warrants (28/07/2021)

Previous close
0.0876
0   0%

Share volume: 0
Last Updated: Tue 03 Aug 2021 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$0.09
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.09
P/E Ratio 
0.00
DAY RANGE
$0.05 - $0.09
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
13.493 M
YIELD 
N/A
SHARES OUTSTANDING 
986.842 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Shai Yarkoni
Region: US
Website: cellect.co
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue, that aims to improve a variety of stem cell-based therapies.

Recent news